Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure.

AIMS In addition to diabetes mellitus, less severe abnormalities of glucose and insulin metabolism may be related to functional status in patients with heart failure. We examined the relationship of hyperglycaemia (> or =6.1 mmol. l(-1)) and hyperinsulinaemia (> or =11.2 mU. l(-1)) to functional status and cardiac function in patients with heart failure. METHODS AND RESULTS Fasting plasma glucose and insulin levels were obtained in 663 heart failure patients. The average left ventricular ejection fraction was 0.28+/-0.07, 63% were in New York Heart Association Functional Class (NYHA-FC) I/II and 37% were in NYHA-FC III/IV. Twenty seven percent had diabetes mellitus, but an additional 8% had undiagnosed diabetes mellitus (glucose > or =7 mmol. l(-1)) and 9% had glucose levels between 6.1 and 7 mmol. l(-1), so that a total of 43% (287) of patients had elevated glucose levels (> or =6.1 mmol. l(-1)). In general, more diabetic patients had NYHA-FC III/IV symptoms, shorter 6 min walk distances, but similar left ventricular ejection fractions compared to non-diabetic patients. The non-diabetic patients in NYHA-FC III/IV had higher glucose and insulin levels than patients in NYHA-FC I/II (6.3+/-0.2 vs 5.6+/-0.1 mmol. l(-1), P<0.001 and 19.6+/-2.3 vs 10. 2+/-0.6 mU. l(-1), P<0.001). Non-diabetic patients with elevated glucose levels had shorter 6 min walk distances compared to those with normal glucose levels (368.2+/-8 m vs 389.+/-4 m, P=0.02), however, left ventricular ejection fraction was similar. CONCLUSION Glucose abnormalities are extremely common in heart failure patients (43% of patients). Diabetes mellitus and hyperglycaemia or hyperlinsulinaemia in non-diabetic patients were related to worse symptomatic status but not worsening left ventricular ejection fraction compared to patients with normal glucose and insulin levels.

[1]  B. Howard,et al.  Diabetes and cardiovascular disease , 2000, Annual review of medicine.

[2]  J. Widimský,et al.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1998, Diabetes Care.

[3]  C. Sartori,et al.  Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. , 1997, Circulation.

[4]  S. Yusuf,et al.  Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study. , 1997, The Canadian journal of cardiology.

[5]  P. Poole‐Wilson,et al.  Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care , 1997, The Lancet.

[6]  S. Anker,et al.  Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. , 1997, Journal of the American College of Cardiology.

[7]  R. Kelly,et al.  Nitric oxide and nitrovasodilators: similarities, differences, and interactions. , 1996, The American journal of cardiology.

[8]  S. Yusuf,et al.  Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. , 1996, The American journal of cardiology.

[9]  G. Reaven,et al.  Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. , 1996, The New England journal of medicine.

[10]  P. Savage.  Cardiovascular Complications of Diabetes Mellitus: What We Know and What We Need To Know about Their Prevention , 1996, Annals of Internal Medicine.

[11]  P. Sweetnam,et al.  Simple measure of insulin resistance , 1995, The Lancet.

[12]  Alan C. Wilson,et al.  Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: A statewide study , 1995 .

[13]  A. Shehadeh,et al.  Cardiac consequences of diabetes mellitus , 1995, Clinical cardiology.

[14]  G. Lopaschuk,et al.  Regulation of fatty acid oxidation in the mammalian heart in health and disease. , 1994, Biochimica et biophysica acta.

[15]  L. Opie,et al.  Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias , 1994, The Lancet.

[16]  S. Yusuf,et al.  Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: Results of the studies of left ventricular dysfunctions (SOLVD) registry , 1993 .

[17]  [Prevention of congestive heart failure]. , 1993, Herz.

[18]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[19]  S. Julius,et al.  Early Association of Sympathetic Overactivity, Hypertension, Insulin Resistance, and Coronary Risk , 1992, Journal of cardiovascular pharmacology.

[20]  G. Paolisso,et al.  Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure. , 1991, Metabolism: clinical and experimental.

[21]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[22]  D. Levy,et al.  Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). , 1991, The American journal of cardiology.

[23]  S. Frostick,et al.  Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow. , 1988, Circulation.

[24]  J. Sundsfjord,et al.  Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. , 1988, The Journal of clinical endocrinology and metabolism.

[25]  S. Houle,et al.  Optimized count-based scintigraphic left ventricular volume measurement. , 1985, The Canadian journal of cardiology.

[26]  G H Guyatt,et al.  Effect of encouragement on walking test performance. , 1984, Thorax.

[27]  J. Wilson,et al.  Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. , 1984, Circulation.

[28]  E F Cook,et al.  Comparative Reproducibility and Validity of Systems for Assessing Cardiovascular Functional Class: Advantages of a New Specific Activity Scale , 1981, Circulation.

[29]  W. Kannel,et al.  Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.